ZBNA
RPRX icon

Zions Bancorporation, National Association’s Royalty Pharma RPRX Stock Holding History

Zions Bancorporation, National Association’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$22.7K Buy
474
+64
+16% +$2.8K ﹤0.01% 709
2025
Q4 		$15.8K Buy
+410
New +$15.6K ﹤0.01% 767

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Zions Bancorporation, National Association's RPRX Position: Q1 2026 in Review

Zions Bancorporation, National Association increased its Royalty Pharma (RPRX) stake by 16% in Q1 2026, buying an estimated $2.8K and bringing the position to 474 shares worth $22.7K. The position accounts for ﹤0.01% of the portfolio, ranked #709.

Zions Bancorporation, National Association first reported a position in RPRX in Q4 2025 and has held it in 2 quarters since. 588 funds tracked by Wall St. Rank hold RPRX as of Q1 2026.

  • Zions Bancorporation, National Association held 474 shares of Royalty Pharma worth $22.7K as of Q1 2026.
  • Zions Bancorporation, National Association bought 64 Royalty Pharma shares in Q1 2026, an estimated $2.8K.
  • Royalty Pharma made up ﹤0.01% of Zions Bancorporation, National Association's portfolio in Q1 2026, its #709 holding.
  • Zions Bancorporation, National Association first reported a position in Royalty Pharma in Q4 2025 and has held it in 2 quarters since.
  • 588 funds tracked by Wall St. Rank held Royalty Pharma as of Q1 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q1 2026, filed 8 May 2026.